# Epclusa

NDC: 61958-2205
Generic name: Velpatasvir and Sofosbuvir
Labeler / Manufacturer: Gilead Sciences, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: PELLET
Routes: ORAL
Marketing started: 20210610

FDA application: NDA214187

## Active ingredients

- SOFOSBUVIR: 150 mg/1
- VELPATASVIR: 37.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61958-2205"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61958-2205
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f30631a-ee3b-4cfe-866b-964df3f0a44f